Evidence map›Paper›PMID 32598378›Full record

ReviewPLoS pathogens2020

How MHCII signaling promotes benign host-microbiota interactions.

Mary Melissa Roland, Ahmed Dawood Mohammed, Jason Lee Kubinak

Abstract readReview
In one paragraph

Review in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. RETRACTED: Effect ofMicroorganisms · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Host gene effects on gut microbiota in type 1 diabetes.Biochemical Society transactions · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mary Melissa RolandUniversity of South Carolina School of Medicine, Department of Pathology, Microbiology, and Immunology, Columbia, South Carolina, United States of America.
Ahmed Dawood MohammedUniversity of South Carolina School of Medicine, Department of Pathology, Microbiology, and Immunology, Columbia, South Carolina, United States of America.
Jason Lee KubinakUniversity of South Carolina School of Medicine, Department of Pathology, Microbiology, and Immunology, Columbia, South Carolina, United States of America.ORCID 0000-0001-9866-8225

Funding

Targeting early ceramide elevation in pre-symptomatic eczemaP20GM103641 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ENOS, REILLY, NAGARKATTI, PRAKASH S · 2012 to 2023
$20.7M
B-cell-intrinsic MHCII Signaling is a Diversifying Force of Selection on IgA Repertoires and the Gut MicrobiotaR01AI155887 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KUBINAK, JASON L · 2021 to 2025
$2.1M
Mechanism of MHC heterozygote advantage during anti-commensal germinal center B cell selectionR21AI142409 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KUBINAK, JASON L · 2019 to 2020
$410k
NIAID NIH HHS R01 AI155887NIAID NIH HHS R21 AI142409NIGMS NIH HHS P20 GM103641
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHistocompatibility Antigens Class IIHost Microbial InteractionsHumansMicrobiotaSignal TransductionHistocompatibility Antigens Class II

Identifiers

PMID32598378
PMCPMC7323949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.